Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:684 (18 September), doi:10.1136/bmj.329.7467.684-a
| The first 150 words of the full text of this article appear below. |
EDITORWe agree with Pollard and Savulescu that the new guidelines directed towards recovering costs for HIV from overseas visitors are not only unethical but also could lead to an escalation of new cases in the United Kingdom by failing to treat highly infectious cases with advanced immunosuppression.1
In this hospital most new HIV cases present with low CD4 cell counts and medical complications that usually require urgent treatment. These patients invariably have minimal financial resources. Pre-test HIV discussion with these people at high risk includes treatment issues and the likelihood that highly active antiretroviral treatment (HAART) will be recommended, if not immediately then in the near future. If the guidelines are to be implemented this discussion will have to include the information that the government will seek to recover medical costs from patients who may be extremely ill with conditions causing respiratory distress, such as Pneumocystis carinii pneumonia
Nigel O'Farrell, consultant physician
Nigel.O'Farrell@eht.nhs.uk
Stephen Ash, consultant physician, Paul Fox, consultant physician, William Lynn, consultant physician
Pasteur Suite, Ealing Hospital, London UB1 3HW
Read all Rapid Responses